Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
Phuong N PhamJoshua D BrownPublished in: BMC cardiovascular disorders (2019)
Apixaban users had the highest overall adherence despite twice-daily dosing versus once-daily dosing for rivaroxaban. These findings can be useful for formulary decision-making and when assessing treatment options.
Keyphrases
- direct oral anticoagulants
- atrial fibrillation
- venous thromboembolism
- newly diagnosed
- decision making
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- physical activity
- heart failure
- percutaneous coronary intervention
- glycemic control
- type diabetes
- coronary artery disease
- metabolic syndrome
- pulmonary embolism
- adipose tissue
- left ventricular